| 01/12/17 | 15:00:01 | 1 Dec 2017 | | Total Voting Rights | RNS |
| 28/11/17 | 07:00:03 | 28 Nov 2017 | | EMA accepts Tagrisso submission for 1st-line nsclc | RNS |
| 27/11/17 | 07:00:06 | 27 Nov 2017 | | AZ submits Tagrisso in Japan for 1st-line nsclc | RNS |
| 15/11/17 | 07:00:01 | 15 Nov 2017 | | AZ Fasenra receives FDA approval for severe asthma | RNS |
| 10/11/17 | 11:35:01 | 10 Nov 2017 | | BENRALIZUMAB POSITIVE CHMP IN EOSINOPHILIC ASTHMA | RNS |
| 09/11/17 | 07:00:06 | 9 Nov 2017 | | AZN: Year-To-Date and Q3 2017 Results Announcement | RNS |
| 01/11/17 | 15:00:01 | 1 Nov 2017 | | Total Voting Rights | RNS |
| 01/11/17 | 07:03:14 | 1 Nov 2017 | | ASTRAZENECA AND ASPEN COMPLETE ANAESTHETICS DEAL | RNS |
| 01/11/17 | 07:00:04 | 1 Nov 2017 | | AstraZeneca tralokinumab update in severe asthma | RNS |
| 31/10/17 | 17:05:21 | 31 Oct 2017 | | US FDA approves AstraZeneca's Calquence for MCL | RNS |
| 23/10/17 | 08:05:30 | 23 Oct 2017 | | AZ and MSD rapidly advance Lynparza in Japan | RNS |
| 23/10/17 | 08:00:03 | 23 Oct 2017 | | US FDA approves Bydureon BCise for type-2 diabetes | RNS |
| 18/10/17 | 08:00:04 | 18 Oct 2017 | | FDA Priority Review for Lynparza in breast cancer | RNS |
| 17/10/17 | 08:00:02 | 17 Oct 2017 | | FDA accepts sBLA file for Imfinzi; priority review | RNS |
| 09/10/17 | 08:00:04 | 9 Oct 2017 | | FDA grants Tagrisso BTD for 1st-line EGFR nsclc | RNS |
| 02/10/17 | 16:00:01 | 2 Oct 2017 | | Total Voting Rights | RNS |
| 26/09/17 | 13:00:01 | 26 Sept 2017 | | Director/PDMR Shareholding | RNS |
| 14/09/17 | 08:00:05 | 14 Sept 2017 | | Aspen acquires remaining rights to AZ anaesthetics | RNS |
| 11/09/17 | 08:00:05 | 11 Sept 2017 | | IMFINZI superior PFS in Stage III lung cancer | RNS |
| 11/09/17 | 08:00:05 | 11 Sept 2017 | | Tagrisso potential standard of care in lung cancer | RNS |
| 07/09/17 | 08:00:02 | 7 Sept 2017 | | AZ Duaklir improves lung function in COPD patients | RNS |
| 07/09/17 | 08:00:02 | 7 Sept 2017 | | AZ tezepelumab cuts exacerbations in severe asthma | RNS |
| 05/09/17 | 08:00:04 | 5 Sept 2017 | | Directorate Change | RNS |
| 01/09/17 | 16:00:01 | 1 Sept 2017 | | Total Voting Rights | RNS |
| 18/08/17 | 08:00:03 | 18 Aug 2017 | | Lynparza gets broad FDA approval in ovarian cancer | RNS |
| 16/08/17 | 08:00:05 | 16 Aug 2017 | | Directorate Change | RNS |
| 14/08/17 | 17:30:01 | 14 Aug 2017 | | Holding(s) in Company | RNS |
| 10/08/17 | 14:30:01 | 10 Aug 2017 | | Publication of a Prospectus | RNS |
| 02/08/17 | 08:00:19 | 2 Aug 2017 | | AZ acalabrutinib submission accepted by US FDA | RNS |
| 01/08/17 | 16:00:01 | 1 Aug 2017 | | Total Voting Rights | RNS |
| 01/08/17 | 08:00:19 | 1 Aug 2017 | | BTD for AZ's acalabrutinib in mantle cell lymphoma | RNS |
| 31/07/17 | 08:00:06 | 31 Jul 2017 | | Imfinzi granted BTD by US FDA for Stage III nsclc | RNS |
| 28/07/17 | 12:00:01 | 28 Jul 2017 | | Director/PDMR Shareholding | RNS |
| 27/07/17 | 08:15:01 | 27 Jul 2017 | | Tagrisso significantly improves FLAURA | RNS |
| 27/07/17 | 08:11:03 | 27 Jul 2017 | | AZ reports initial results from MYSTIC lung trial | RNS |
| 27/07/17 | 08:06:27 | 27 Jul 2017 | | AZ & MERCK ESTABLISH STRATEGIC ONCOLOGY DEAL | RNS |
| 27/07/17 | 08:00:10 | 27 Jul 2017 | | AstraZeneca PLC - H1 2017 Results | RNS |
| 26/07/17 | 17:46:05 | 26 Jul 2017 | | Faslodex receives EU approval for 1L breast cancer | RNS |
| 21/07/17 | 16:45:01 | 21 Jul 2017 | | Holding(s) in Company | RNS |
| 03/07/17 | 15:59:58 | 3 Jul 2017 | | Total Voting Rights | RNS |
| 03/07/17 | 08:00:01 | 3 Jul 2017 | | AZ COMPLETES SELOKEN AGREEMENT WITH RECORDATI | RNS |
| 03/07/17 | 08:00:00 | 3 Jul 2017 | | AZ COMPLETES ZOMIG DIVESTMENT WITH GR�œNENTHAL | RNS |
| 23/06/17 | 13:46:46 | 23 Jun 2017 | | Faslodex CHMP positive opinion in 1L breast cancer | RNS |
| 07/06/17 | 08:13:03 | 7 Jun 2017 | | AZ agreement with Grünenthal for rights to Zomig | RNS |
| 06/06/17 | 08:00:05 | 6 Jun 2017 | | ASTRAZENECA PRICES A $2BN BOND ISSUE | RNS |
| 05/06/17 | 08:00:04 | 5 Jun 2017 | | LYNPARZA: SIGNIFICANT PFS IN BRCAm BREAST CANCER | RNS |
| 01/06/17 | 16:00:02 | 1 Jun 2017 | | Block listing Interim Review | RNS |
| 01/06/17 | 16:00:01 | 1 Jun 2017 | | Total Voting Rights | RNS |
| 31/05/17 | 08:00:05 | 31 May 2017 | | Directorate Change | RNS |
| 24/05/17 | 16:00:02 | 24 May 2017 | | Director/PDMR Shareholding | RNS |
